09/18/2026
Early detection is critical. A timely, accurate diagnosis can do more than confirm prostate cancer — it can help inform the course of a patient’s care.
Our prostate pathology expertise provides clinical insight to help guide treatment decisions. In addition to Han and Partin tables, every report with a positive result includes Grade Groups and clinically relevant histologic details, including intraductal carcinoma and percentage of Gleason pattern 4, with access to prognostic and biomarker testing.
Because when prostate cancer is detected, the details matter. Learn more here: https://bit.ly/4i6mhLj.